- Home
- MCHP vs TEVA Comparison
MCHP vs TEVA Comparison
Compare MCHP & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MCHP | TEVA |
|---|---|---|
| Founded | 1989 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.7B | 40.5B |
| IPO Year | 2004 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MCHP | TEVA |
|---|---|---|
| Price | $81.64 | $36.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 22 | 8 |
| Target Price | ★ $85.59 | $38.63 |
| AVG Volume (30 Days) | ★ 10.8M | 5.2M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | ★ 2300.00 | 183.45 |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $5,349,500,000.00 | N/A |
| Revenue This Year | $8.12 | N/A |
| Revenue Next Year | $22.55 | $2.97 |
| P/E Ratio | $219.30 | ★ N/A |
| Revenue Growth | ★ 34.38 | N/A |
| 52 Week Low | $48.52 | $17.33 |
| 52 Week High | $105.91 | $37.35 |
Technical Indicators
Market Signals| Indicator | MCHP | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 51.29 | 68.02 |
| Support Level | $79.80 | $30.42 |
| Resistance Level | $101.29 | $37.17 |
| Average True Range (ATR) | 3.63 | 0.99 |
| MACD | 1.07 | 0.43 |
| Stochastic Oscillator | 76.93 | 96.30 |
Price Performance
Historical ComparisonAbout MCHP Microchip Technology Incorporated
Microchip Technology became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.